NAPLEX (North American Pharmacist Licensure Examination) Practice Exam

Disable ads (and more) with a membership for a one time $2.99 payment

Prepare for the NAPLEX (North American Pharmacist Licensure Examination) Test. Study with flashcards and multiple choice questions, each question has hints and explanations. Get ready for your exam!

Start Multiple Choice Practice Test
Start Flash Cards

Each practice test/flash card set has 50 randomly selected questions from a bank of over 500. You'll get a new set of questions each time!

Practice this question and more.

How often must an Assessment of Risk be reviewed for drugs with lower risk?

  1. Every 6 months

  2. At least every 12 months

  3. Every 2 years

  4. Every month

The correct answer is: At least every 12 months

An Assessment of Risk must be reviewed regularly in order to ensure the safety and efficacy of a drug. While an Assessment of Risk for higher risk drugs may need to be reviewed every 6 months or even monthly, for drugs with lower risk, a review at least every 12 months is sufficient. This is because lower risk drugs typically have a lower likelihood of causing adverse effects and therefore require less frequent monitoring and assessment. Options A, C, and D are incorrect because they suggest review frequencies that are either too frequent or too infrequent for drugs with lower risk.

More Questions Like This